FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016243530> ?p ?o ?g. }

• W2016243530 endingPage "3210" @default.
• W2016243530 startingPage "3201" @default.
• W2016243530 abstract "An effective malaria vaccine remains a global health priority. Recombinant adenoviruses are a promising vaccine platform, and Plasmodium falciparum apical membrane antigen 1 (AMA1) and merozoite surface protein 1-42 (MSP1(42)) are leading blood stage vaccine candidates. We evaluated the importance of surface antigen localization and glycosylation on the immunogenicity of adenovector delivered AMA1 and MSP1(42) and assessed the ability of these vaccines to induce functional antibody responses capable of inhibiting parasite growth in vitro. Adenovector delivery induced unprecedented levels of biologically active antibodies in rabbits as indicated by the parasite growth inhibition assay. These responses were as potent as published results using any other vaccine system, including recombinant protein in adjuvant. The cell surface associated and glycosylated forms of AMA1 and MSP1(42) elicited 99% and 60% inhibition of parasite growth, respectively. Antigens that were expressed at the cell surface and glycosylated were much better than intracellular antigens at inducing antibody responses. Good T cell responses were observed for all forms of AMA1 and MSP1(42). Antigen-specific antibody responses, but typically not T cell responses, were boosted by a second administration of adenovector. These data highlight the importance of rational vaccine design and support the advancement of adenovector delivery technology for a malaria vaccine." @default.
• W2016243530 created "2016-06-24" @default.
• W2016243530 creator A5016041349 @default.
• W2016243530 creator A5020245627 @default.
• W2016243530 creator A5024355659 @default.
• W2016243530 creator A5028156362 @default.
• W2016243530 creator A5030177021 @default.
• W2016243530 creator A5036689148 @default.
• W2016243530 creator A5037896874 @default.
• W2016243530 creator A5049896244 @default.
• W2016243530 creator A5055114123 @default.
• W2016243530 creator A5065524991 @default.
• W2016243530 creator A5068723533 @default.
• W2016243530 creator A5069745437 @default.
• W2016243530 creator A5081023082 @default.
• W2016243530 creator A5087303099 @default.
• W2016243530 date "2010-04-01" @default.
• W2016243530 modified "2023-09-26" @default.
• W2016243530 title "Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth" @default.
• W2016243530 cites W1570679758 @default.
• W2016243530 cites W1813288331 @default.
• W2016243530 cites W1964149115 @default.
• W2016243530 cites W1964629907 @default.
• W2016243530 cites W1970436087 @default.
• W2016243530 cites W1970594700 @default.
• W2016243530 cites W1978153917 @default.
• W2016243530 cites W1986169276 @default.
• W2016243530 cites W1990129128 @default.
• W2016243530 cites W2003955696 @default.
• W2016243530 cites W2033742471 @default.
• W2016243530 cites W2037699348 @default.
• W2016243530 cites W2042323803 @default.
• W2016243530 cites W2052669146 @default.
• W2016243530 cites W2053384778 @default.
• W2016243530 cites W2059106422 @default.
• W2016243530 cites W2069460651 @default.
• W2016243530 cites W2080757497 @default.
• W2016243530 cites W2089777481 @default.
• W2016243530 cites W2098286914 @default.
• W2016243530 cites W2105809563 @default.
• W2016243530 cites W2105920586 @default.
• W2016243530 cites W2109222674 @default.
• W2016243530 cites W2114941904 @default.
• W2016243530 cites W2119822849 @default.
• W2016243530 cites W2121429345 @default.
• W2016243530 cites W2122070396 @default.
• W2016243530 cites W2123648591 @default.
• W2016243530 cites W2126082637 @default.
• W2016243530 cites W2136390564 @default.
• W2016243530 cites W2139968244 @default.
• W2016243530 cites W2140423552 @default.
• W2016243530 cites W2146223790 @default.
• W2016243530 cites W2148123079 @default.
• W2016243530 cites W2148255623 @default.
• W2016243530 cites W2152998216 @default.
• W2016243530 cites W2153670011 @default.
• W2016243530 cites W2154186746 @default.
• W2016243530 cites W2160612361 @default.
• W2016243530 cites W2162891851 @default.
• W2016243530 cites W2163053975 @default.
• W2016243530 cites W2164209355 @default.
• W2016243530 cites W2168202434 @default.
• W2016243530 cites W2169962588 @default.
• W2016243530 cites W2170874107 @default.
• W2016243530 cites W2171988175 @default.
• W2016243530 cites W2186807264 @default.
• W2016243530 cites W2465969139 @default.
• W2016243530 doi "https://doi.org/10.1016/j.vaccine.2010.02.024" @default.
• W2016243530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20188680" @default.
• W2016243530 hasPublicationYear "2010" @default.
• W2016243530 type Work @default.
• W2016243530 sameAs 2016243530 @default.
• W2016243530 citedByCount "38" @default.
• W2016243530 countsByYear W20162435302012 @default.
• W2016243530 countsByYear W20162435302013 @default.
• W2016243530 countsByYear W20162435302014 @default.
• W2016243530 countsByYear W20162435302015 @default.
• W2016243530 countsByYear W20162435302016 @default.
• W2016243530 countsByYear W20162435302017 @default.
• W2016243530 countsByYear W20162435302018 @default.
• W2016243530 countsByYear W20162435302019 @default.
• W2016243530 countsByYear W20162435302020 @default.
• W2016243530 crossrefType "journal-article" @default.
• W2016243530 hasAuthorship W2016243530A5016041349 @default.
• W2016243530 hasAuthorship W2016243530A5020245627 @default.
• W2016243530 hasAuthorship W2016243530A5024355659 @default.
• W2016243530 hasAuthorship W2016243530A5028156362 @default.
• W2016243530 hasAuthorship W2016243530A5030177021 @default.
• W2016243530 hasAuthorship W2016243530A5036689148 @default.
• W2016243530 hasAuthorship W2016243530A5037896874 @default.
• W2016243530 hasAuthorship W2016243530A5049896244 @default.
• W2016243530 hasAuthorship W2016243530A5055114123 @default.
• W2016243530 hasAuthorship W2016243530A5065524991 @default.
• W2016243530 hasAuthorship W2016243530A5068723533 @default.
• W2016243530 hasAuthorship W2016243530A5069745437 @default.
• W2016243530 hasAuthorship W2016243530A5081023082 @default.
• W2016243530 hasAuthorship W2016243530A5087303099 @default.
• W2016243530 hasConcept C147483822 @default.

• next